Constitutive activity of the dopamine (D 5 ) receptor, highly expressed in CA1 hippocampal neurons, selectively reduces Ca V 3.2 and Ca V 3.3 currents
British Journal of Pharmacology · 2023
DOI: 10.1111/bph.16006 ↗At a glance
Journal article in British Journal of Pharmacology, 2023. Written by Emilio Román Mustafá and 5 co-authors. Institution: Electrophysiology Laboratory of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission…. Major MEDLINE topics: Dopamine, Receptors, Dopamine D1. Cited 4 times so far (Crossref); 87 references. Funded by: Consejo Nacional de Investigaciones Científicas y Técnicas, Fondo para la Investigación Científica y Tecnológica, Universidad Nacional de La Plata.
Abstract (original language)
Background and Purpose Ca V 3.1‐3 currents differentially contribute to neuronal firing patterns. Ca V 3 are regulated by G protein‐coupled receptors (GPCRs) activity, but information about Ca V 3 as targets of the constitutive activity of GPCRs is scarce. We investigate the impact of D 5 recpetor constitutive activity, a GPCR with high levels of basal activity, on Ca V 3 functionality. D 5 recpetor and Ca V 3 are expressed in the hippocampus and have been independently linked to pathophysiological states associated with epilepsy. Experimental Approach Our study models were HEK293T cells heterologously expressing D 1 or D 5 receptor and Ca V 3.1‐3, and mouse brain slices containing the hippocampus. We used chlorpromazine (D 1 /D 5 inverse agonist) and a D 5 receptor mutant lacking constitutive activity as experimental tools. We measured Ca V 3 currents and excitability parameters using the patch‐clamp technique. We completed our study with computational modelling and imaging technique. Key Results We found a higher sensitivity to TTA‐P2 (Ca V 3 blocker) in CA1 pyramidal neurons obtained from chlorpromazine‐treated animals compared with vehicle‐treated animals. We found that Ca V 3.2 and Ca V 3.3—but not Ca V 3.1—are targets of D 5 receptor constitutive activity in HEK293T cells. Finally, we found an increased firing rate in CA1 pyramidal neurons from chlorpromazine‐treated animals in comparison with vehicle‐treated animals. Similar changes in firing rate were observed on a neuronal model with controlled Ca V 3 currents levels. Conclusions and Implications Native hippocampal Ca V 3 and recombinant Ca V 3.2‐3 are sensitive to D 5 receptor constitutive activity. Manipulation of D 5 receptor constitutive activity could be a valuable strategy to control neuronal excitability, especially in exacerbated conditions such as epilepsy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Electrophysiology Laboratory of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of…
ORCID profiles: Jesica Raingo
Funding
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Fondo para la Investigación Científica y Tecnológica
- Universidad Nacional de La Plata
Cite
APA
Mustafá, E. R., McCarthy, C. I., Portales, A. E., Cordisco Gonzalez, S., Rodríguez, S. S., & Raingo, J. (2023). Constitutive activity of the dopamine (D 5 ) receptor, highly expressed in CA1 hippocampal neurons, selectively reduces Ca V 3.2 and Ca V 3.3 currents. British Journal of Pharmacology. https://doi.org/10.1111/bph.16006
Vancouver
Mustafá ER, McCarthy CI, Portales AE, Cordisco Gonzalez S, Rodríguez SS, Raingo J. Constitutive activity of the dopamine (D 5 ) receptor, highly expressed in CA1 hippocampal neurons, selectively reduces Ca V 3.2 and Ca V 3.3 currents. British Journal of Pharmacology. 2023. doi:10.1111/bph.16006
BibTeX
@article{Mustaf2023,
author = {Mustafá, Emilio Román and McCarthy, Clara Inés and Portales, Andrea Estefanía and Cordisco Gonzalez, Santiago and Rodríguez, Silvia Susana and Raingo, Jesica},
title = {Constitutive activity of the dopamine (D 5 ) receptor, highly expressed in CA1 hippocampal neurons, selectively reduces Ca V 3.2 and Ca V 3.3 currents},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16006}
}
EUVIMED